Skip to main content

Epidemiology of Parkinson’s disease

Abstract

Parkinson’s disease (PD) affects 1–2 per 1000 of the population at any time. PD prevalence is increasing with age and PD affects 1% of the population above 60 years. The main neuropathological finding is α-synuclein-containing Lewy bodies and loss of dopaminergic neurons in the substantia nigra, manifesting as reduced facilitation of voluntary movements. With progression of PD, Lewy body pathology spreads to neocortical and cortical regions. PD is regarded as a movement disorder with three cardinal signs: tremor, rigidity and bradykinesia. A recent revision of the diagnostic criteria excludes postural instability as a fourth hallmark and defines supportive criteria, absolute exclusion criteria and red flags. Non-motor symptoms in PD have gained increasing attention and both motor and non-motor signs are now included among the supportive criteria. The cause of PD is unknown in most cases. Genetic risk factors have been identified, including monogenetic causes that are rare in unselected populations. Some genetic factor can be identified in 5–10% of the patients. Several environmental factors are associated with increased risk of PD. Autopsy studies show that the clinical diagnosis of PD is not confirmed at autopsy in a significant proportion of patients. Revised diagnostic criteria are expected to improve the clinician´s accuracy in diagnosing PD. Increasing knowledge on genetic and environmental risk factors of PD will probably elucidate the cause of this disease within the near future.

This is a preview of subscription content, access via your institution.

References

  • Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW (2001) Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology 57(3):456–462

    CAS  Article  PubMed  Google Scholar 

  • Alves G, Muller B, Herlofson K, HogenEsch I, Telstad W, Aarsland D, Tysnes OB, Larsen JP (2009) Incidence of Parkinson’s disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 80(8):851–857. doi:10.1136/jnnp.2008.168211

    CAS  Article  PubMed  Google Scholar 

  • Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JP (2016) Environmental risk factors and Parkinson’s disease: an umbrella review of meta-analyses. Parkinsonism Relat Disord 23:1–9. doi:10.1016/j.parkreldis.2015.12.008

    Article  PubMed  Google Scholar 

  • Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211

    Article  PubMed  Google Scholar 

  • de Lau LM, Breteler MM (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5(6):525–535. doi:10.1016/S1474-4422(06)70471-9

    Article  PubMed  Google Scholar 

  • de Rijk MC, Breteler MM, Graveland GA, Ott A, Grobbee DE, van der Meche FG, Hofman A (1995) Prevalence of Parkinson’s disease in the elderly: the Rotterdam Study. Neurology 45(12):2143–2146

    Article  PubMed  Google Scholar 

  • de Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, Fratiglioni L, Lobo A, Martinez-Lage J, Trenkwalder C, Hofman A (2000) Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54(11 Suppl 5):S21–S23

    PubMed  Google Scholar 

  • Gaare JJ, Skeie GO, Tzoulis C, Larsen JP, Tysnes OB (2016). Familial aggregation of Parkinson\s disease may affect progression of motor symptoms and dementia. Mov Disord. doi:10.1002/mds.26856

    PubMed  Google Scholar 

  • Garcia-Ruiz PJ, Chaudhuri KR, Martinez-Martin P (2014) Non-motor symptoms of Parkinson’s disease a review from the past. J Neurol Sci 338(1–2):30–33. doi:10.1016/j.jns.2014.01.002

    Article  PubMed  Google Scholar 

  • Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39

    CAS  Article  PubMed  Google Scholar 

  • Gilks WP, Abou-Sleiman PM, Gandhi S, Jain S, Singleton A, Lees AJ, Shaw K, Bhatia KP, Bonifati V, Quinn NP, Lynch J, Healy DG, Holton JL, Revesz T, Wood NW (2005) A common LRRK2 mutation in idiopathic Parkinson’s disease. Lancet 365(9457):415–416. doi:10.1016/S0140-6736(05)17830-1

    CAS  PubMed  Google Scholar 

  • Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H (2007) Olfactory loss may be a first sign of idiopathic Parkinson’s disease. Mov Disord 22(6):839–842. doi:10.1002/mds.21413

    Article  PubMed  Google Scholar 

  • Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease. Neurology 57(8):1497–1499

    CAS  Article  PubMed  Google Scholar 

  • Jankovic M, Svetel M, Kostic V (2015) Frequency of REM sleep behavior disorders in patients with Parkinson’s disease. Vojnosanit Pregl 72(5):442–446

    Article  PubMed  Google Scholar 

  • Kalia LV, Lang AE (2015) Parkinson’s disease. Lancet 386(9996):896–912. doi:10.1016/S0140-6736(14)61393-3

    CAS  Article  PubMed  Google Scholar 

  • Larsen JP, Dupont E, Tandberg E (1994) Clinical diagnosis of Parkinson’s disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand 89(4):242–251

    CAS  Article  PubMed  Google Scholar 

  • Lee PC, Liu LL, Sun Y, Chen YA, Liu CC, Li CY, Yu HL, Ritz B (2016) Traffic-related air pollution increased the risk of Parkinson’s disease in Taiwan: a nationwide study. Environ Int 96:75–81. doi:10.1016/j.envint.2016.08.017

    CAS  Article  PubMed  Google Scholar 

  • Lesage S, Brice A (2012) Role of mendelian genes in “sporadic” Parkinson’s disease. Parkinsonism Relat Disord 18(Suppl 1):S66–S70. doi:10.1016/S1353-8020(11)70022-0

    Article  PubMed  Google Scholar 

  • Lill CM (2016) Genetics of Parkinson’s disease. Mol Cell Probes 30(6):386–396. doi:10.1016/j.mcp.2016.11.001

    CAS  Article  PubMed  Google Scholar 

  • Linder J, Stenlund H, Forsgren L (2010) Incidence of Parkinson’s disease and parkinsonism in northern Sweden: a population-based study. Mov Disord 25(3):341–348. doi:10.1002/mds.22987

    Article  PubMed  Google Scholar 

  • Liu WM, Wu RM, Lin JW, Liu YC, Chang CH, Lin CH (2016) Time trends in the prevalence and incidence of Parkinson’s disease in Taiwan: a nationwide, population-based study. J Formos Med Assoc 115(7):531–538. doi:10.1016/j.jfma.2015.05.014

    Article  PubMed  Google Scholar 

  • Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015a) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601. doi:10.1002/mds.26424

    Article  PubMed  Google Scholar 

  • Postuma RB, Gagnon JF, Bertrand JA, Genier Marchand D, Montplaisir JY (2015b) Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. Neurology 84(11):1104–1113. doi:10.1212/WNL.0000000000001364

    Article  PubMed  PubMed Central  Google Scholar 

  • Rana HQ, Balwani M, Bier L, Alcalay RN (2013) Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling. Genet Med Off J Am Coll Med Genet 15(2):146–149. doi:10.1038/gim.2012.107

    CAS  Google Scholar 

  • Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G (2016) Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology 86(6):566–576. doi:10.1212/WNL.0000000000002350

    Article  PubMed  Google Scholar 

  • Rocca WA, Bower JH, McDonnell SK, Peterson BJ, Maraganore DM (2001) Time trends in the incidence of Parkinsonism in Olmsted County, Minnesota. Neurology 57(3):462–467

    CAS  Article  PubMed  Google Scholar 

  • Savica R, Cannon-Albright LA, Pulst S (2016a) Familial aggregation of Parkinson disease in Utah: a population-based analysis using death certificates. Neurol Genet 2(2):e65. doi:10.1212/NXG.0000000000000065

    Article  PubMed  PubMed Central  Google Scholar 

  • Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA (2016b) Time trends in the incidence of Parkinson disease. JAMA Neurol 73(8):981–989. doi:10.1001/jamaneurol.2016.0947

    Article  PubMed  Google Scholar 

  • Seljeseth YM, Vollset SE, Tysnes O-B (2000) Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology 55:1262–1266

    CAS  Article  PubMed  Google Scholar 

  • Stirpe P, Hoffman M, Badiali D, Colosimo C (2016) Constipation: an emerging risk factor for Parkinson’s disease? Eur J Neurol. doi:10.1111/ene.13082

    PubMed  Google Scholar 

  • Sveinbjornsdottir S, Hicks AA, Jonsson T, Petursson H, Gugmundsson G, Frigge ML, Kong A, Gulcher JR, Stefansson K (2000) Familial aggregation of Parkinson’s disease in Iceland. N Engl J Med 343(24):1765–1770. doi:10.1056/NEJM200012143432404

    CAS  Article  PubMed  Google Scholar 

  • Svensson E, Henderson VW, Borghammer P, Horvath-Puho E, Sorensen HT (2016) Constipation and risk of Parkinson’s disease: a Danish population-based cohort study. Parkinsonism Relat Disord 28:18–22. doi:10.1016/j.parkreldis.2016.05.016

    Article  PubMed  Google Scholar 

  • Thenganatt MA, Jankovic J (2014) Parkinson disease subtypes. JAMA Neurol 71(4):499–504. doi:10.1001/jamaneurol.2013.6233

    Article  PubMed  Google Scholar 

  • Tolosa E, Wenning G, Poewe W (2006) The diagnosis of Parkinson’s disease. Lancet Neurol 5(1):75–86. doi:10.1016/S1474-4422(05)70285-4

    Article  PubMed  Google Scholar 

  • Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM (2003) Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157(11):1015–1022

    Article  Google Scholar 

  • von Campenhausen S, Bornschein B, Wick R, Botzel K, Sampaio C, Poewe W, Oertel W, Siebert U, Berger K, Dodel R (2005) Prevalence and incidence of Parkinson’s disease in Europe. Eur Neuropsychopharmacol 15(4):473–490. doi:10.1016/j.euroneuro.2005.04.007

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anette Storstein.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tysnes, OB., Storstein, A. Epidemiology of Parkinson’s disease. J Neural Transm 124, 901–905 (2017). https://doi.org/10.1007/s00702-017-1686-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-017-1686-y

Keywords

  • Parkinson’s disease
  • Epidemiology
  • Diagnostic criteria
  • Non-motor symptoms